The Mutation Patterns of <i>MET</i> Gene in Lung Cancer and Brain Tumors: Clinical and Therapeutic Implications
Our study demonstrated that the biological and clinical significance of MET alterations is highly context dependent. In lung cancer, MET serves primarily as a predictive biomarker for targeted therapy, whereas in brain tumors, it functions as a prognostic marker of genomic instability and aggressive disease. These findings advocate for context-specific clinical management strategies.
Authors
- D. Chen
- Yongmeng Li
- Ningning Luo (ORCID: https://orcid.org/0000-0002-1991-1168)
- Minghui Ge
- Yanxiang Zhang
- Yu Zhang
Institutions
- Hebei Medical University (CN)
- Simcere Pharmaceutical (China) (CN)
- Shandong Provincial QianFoShan Hospital (CN)
- First Affiliated Hospital of Hebei Medical University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1002/cam4.71532
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Shandong Province